KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Cash from Operations (2016 - 2025)

Pacira BioSciences has reported Cash from Operations over the past 16 years, most recently at 43689000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 43689000.0 for Q4 2025, up 31.86% from a year ago — trailing twelve months through Dec 2025 was 151994000.0 (down 19.75% YoY), and the annual figure for FY2025 was 151994000.0, down 19.75%.
  • Cash from Operations for Q4 2025 was 43689000.0 at Pacira BioSciences, down from 60834000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PCRX hit a ceiling of 60834000.0 in Q3 2025 and a floor of 12012000.0 in Q2 2025.
  • Median Cash from Operations over the past 5 years was 42345500.0 (2022), compared with a mean of 38351150.0.
  • Biggest five-year swings in Cash from Operations: skyrocketed 292.87% in 2021 and later tumbled 77.44% in 2025.
  • Pacira BioSciences' Cash from Operations stood at 23215000.0 in 2021, then skyrocketed by 81.08% to 42037000.0 in 2022, then rose by 13.2% to 47584000.0 in 2023, then plummeted by 30.37% to 33132000.0 in 2024, then soared by 31.86% to 43689000.0 in 2025.
  • The last three reported values for Cash from Operations were 43689000.0 (Q4 2025), 60834000.0 (Q3 2025), and 12012000.0 (Q2 2025) per Business Quant data.